Case 38-2016. A 52-Year-Old Woman with Recurrent Oligodendroglioma

N Engl J Med. 2016 Dec 15;375(24):2381-2389. doi: 10.1056/NEJMcpc1610101.

Authors

Andrew S Chi¹, Daniel P Cahill¹, Mykol Larvie¹, David N Louis¹

Affiliation

¹ From the Departments of Neurology (A.S.C.), Neurosurgery (D.P.C.), Radiology (M.L.), and Pathology (D.N.L.), Massachusetts General Hospital, and the Departments of Neurology (A.S.C.), Neurosurgery (D.P.C.), Radiology (M.L.), and Pathology (D.N.L.), Harvard Medical School - both in Boston.

PMID: 27974037
DOI: 10.1056/NEJMcpc1610101

No abstract available

Publication types

Case Reports
Clinical Conference

MeSH terms

Antineoplastic Agents, Alkylating / therapeutic use
Biopsy
Brain Neoplasms / drug therapy
Brain Neoplasms / pathology*
Brain Neoplasms / surgery
Chemotherapy, Adjuvant
Dacarbazine / analogs & derivatives
Dacarbazine / therapeutic use
Diagnosis, Differential
Female
Frontal Lobe / pathology*
Frontal Lobe / surgery
Humans
Ki-67 Antigen / metabolism
Magnetic Resonance Imaging
Middle Aged
Mutation
Neoplasm Recurrence, Local / drug therapy
Neoplasm Recurrence, Local / pathology*
Neoplasm Recurrence, Local / surgery
Oligodendroglioma / drug therapy
Oligodendroglioma / pathology*
Oligodendroglioma / surgery
Temozolomide

Substances

Antineoplastic Agents, Alkylating
Ki-67 Antigen
Dacarbazine
Temozolomide